COFORMULATED VIBOSTOLIMAB/PEMBROLIZUMAB IN RELAPSED/REFRACTORY NHL AND MM: AN ANALYSIS OF COHORTS C TO F OF THE PHASE 2 KEYVIBE-004 STUDY

EHA Library, Sylvain Choquet, 419292

INITIAL RESULTS FROM THE PRIZM+ PHASE II PLATFORM STUDY FOR RELAPSED AND REFRACTORY PRIMARY CNS LYMPHOMA:  COHORT 1 ZANUBRUTINIB MONOTHERAPY

EHA Library, Christopher Fox, 419293

ANALYSIS OF LARGE B-CELL LYMPHOMA PATIENTS FAILED AFTER CAR T-CELL THERAPY: SEVERAL FACTORS PREDICTING OUTCOME OF RELAPSED/PROGRESSED PATIENTS ARE ALREADY PRESENT BEFORE CELL INFUSION

EHA Library, Robert Pytlík, 419294

CLINICAL CHARACTERISTICS, TREATMENT OPTIONS AND OUTCOME OF REFRACTORY AND EARLY RELAPSE LARGE B CELL LYMPHOMA (LBCL) PATIENTS INCLUDED IN THE REALYSA COHORT BEFORE CAR T CELLS ERA.

EHA Library, Stephanie Guidez, 419295

SINTILIMAB PLUS GEMOX IS AN EFFECTIVE SALVAGE THERAPY IN PATIENTS WITH REFRACTORY⁄RELAPSING NODAL PERIPHERAL T CELL LYMPHOMAS

EHA Library, Xibin Xiao, 419296

PATIENT CHARACTERISTICS, BURDEN OF DISEASE AND HEALTHCARE UTILIZATION IN DIFFUSE LARGE B-CELL LYMPHOMA – AN ANALYSIS OF GERMAN CLAIMS DATA

EHA Library, Moritz Lehne, 419297

DIAGNOSTIC AND PROGNOSTIC IMPACTS OF RHOA G17V MUTATION IN CELL-FREE DNA ASSESSED BY DROPLET DIGITAL POLYMERASE CHAIN REACTION IN PATIENTS WITH ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

EHA Library, Yi Miao, 419298

WAVELINE-004: UPDATED RESULTS FROM THE PHASE 2 STUDY OF ZILOVERTAMAB VEDOTIN (ZV) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Muhit Ozcan, 419299

ENHANCED EFFICACY AND SAFETY FROM PHASE 2 STUDY OF IMC-001, ANTI-PD-L1 ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA (R/R ENKTL), NASAL TYPE: DISTINKT STUDY

EHA Library, Won Seog Kim, 419300

EARLYMIND, A RETROSPECTIVE MULTICENTER STUDY IN REAL-WORLD SETTINGS TO CHARACTERIZE TAFASITAMAB-LENALIDOMIDE EFFICACY IN TRANSPLANT-INELIGIBLE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Charles Herbaux, 419301

PROGNOSTICATION IN SECONDARY CNS LYMPHOMA PATIENTS TREATED WITH MATRIX OR AN ALTERNATIVE (KORFEL ET AL. NCT01148173) INDUCTION REGIMEN AND AUTOLOGOUS STEM CELL TRANSPLANTATION CONSOLIDATION

EHA Library, Fleur de Groot, 419302

OUTCOMES OF ANTHRACYCLINE-BASED CHEMOIMMUNOTHERAPY IN DE NOVO AND TRANSFORMED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Maximilian Seib, 419303

COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY IN PATIENTS WITH LARGE B-CELL LYMPHOMA IN SINGAPORE

EHA Library, Francesca Lim, 419304

THE PHASE II STUDY OF ZANUBRUTINIB COMBINED WITH R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS WITH SPECIFIC GENE-EXPRESSION

EHA Library, Qunling Zhang, 419305

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE AFTER 5797 SOLID-ORGAN TRANSPLANTS OVER A 30-YEAR PERIOD IN A SINGLE HOSPITAL.

EHA Library, Ana Jiménez Ubieto, 419306

INTELLIGENT INTEGRATION: DEEP LEARNING ENSEMBLE CLASSIFIER FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, GLIOMA, AND BRAIN METASTASIS - A RETROSPECTIVE STUDY

EHA Library, Bihui Pan, 419307

MONOMORPHIC LYMPHOPROLIFERATIVE DISORDERS FOLLOWING HEART TRANSPLANTATION: A SINGLE CENTER EXPERIENCE ON 1055 TRANSPLANTS.

EHA Library, Anna Maria Barbui, 419308

A MULTI-CENTER, OPEN-LABEL, PHASE 1/2 STUDY OF ONCT-808, A ROR1-TARGETING CAR-T CELL THERAPY, IN ADULTS WITH RELAPSED/REFRACTORY (R/R) AGGRESSIVE B CELL LYMPHOMAS (BCL)

EHA Library, Michael L. Wang, 419309

POLATUZUMAB VEDOTIN-INDUCED INNATE IMMUNE CELL INFILTRATION CONTRIBUTES TO ITS ANTITUMOR EFFECT IN A HUMAN DLBCL XENOGRAFT MODEL

EHA Library, Mayu Tomita, 419310

IMPACT OF BCR-IGH DIVERSITY ON PROGNOSIS IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Takahiro Haeno, 419311

MUTANT STAT5B TRIGGERS NK-CELL NEOPLASMS

EHA Library, Dagmar GOTTHARDT, 419312

CD58 GENETIC ALTERATIONS GOVERN ANTITUMOR IMMUNE RESPONSES BY REGULATING PD-L1 AND IDO VIA THE LYN/CD22/SHP1 AXIS IN DLBCL

EHA Library, Xiyue Xu, 419313

INTEGRATION OF [18F]FDG-PET RADIOMICS WITH LIQUID BIOPSY IMPROVES OUTCOME PREDICTION IN NEWLY DIAGNOSED DLBCL PATIENTS

EHA Library, Riccardo Dondolin, 419314

SPECIFIC IMMUNE-MOLECULAR PROFILES DISTINGUISH TESTICULAR DIFFUSE LARGE B-CELL LYMPHOMA FROM NODAL-DLBCL-ABC

EHA Library, Ruben de Groen, 419315

PD-1 AND TIGIT IMMUNE-CHECKPOINT BLOCKADE IN NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA

EHA Library, Maher Gandhi, 419316

CIRCULATING TUMOR DNA ANALYSIS ASSOCIATES WITH PFS WITH ODRONEXTAMAB MONOTHERAPY IN R/R FL AND DLBCL: IDENTIFICATION OF MRD STATUS AND HIGH-RISK SUBGROUPS FROM THE PHASE 2 ELM-2 STUDY

EHA Library, David Tucker, 419317

UNRAVELING THE MECHANISMS OF BCL7A-MEDIATED TUMOR SUPPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA: A MULTI-OMIC APPROACH

EHA Library, Fernando Montenegro Elvira, 419318

ALK INHIBITORS ENHANCE PHAGOCYTOSIS INDUCED BY CD47 BLOCKADE IN SENSITIVE AND RESISTANT ALK+ ALCL

EHA Library, Federica Malighetti, 419319

MICRORNA-1181, UPREGULATED IN BONE MARROW-DERIVED EXTRACELLULAR VESICLES, PROMOTES REDUCED PROLIFERATION CAPACITY AND INCREASED APOPTOSIS OF DLBCL CELLS

EHA Library, Inna Tzoran, 419320

CD19 EXPRESSION PERSISTS IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENT BIOPSIES AFTER TREATMENT WITH TAFASITAMAB

EHA Library, Diana Alvarez Arias, 419321

APAF-1 DOWNREGULATION PROMOTES ANGIOIMMUNOBLASTIC T CELL LYMPHOMA.

EHA Library, Barbara Chalhoub, 419322

UNCOVERING A UNIQUE LEUKEMIC CLONE OF KLRG1-CD8+ EFFECTOR T CELLS IN T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA SENSITIVE TO PI3K INHIBITOR: A PILOT TRIAL

EHA Library, Ruonan Li, 419323

GENE EXPRESSION PROFILING OF RELAPSED AND REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA REVEALS ENRICHMENT OF IMMUNE SIGNALING PATHWAYS

EHA Library, Ya Hwee Tan, 419324

THE MUTATIONAL LANDSCAPE AND ITS PROGNOSTIC IMPACT IN CHINESE PEDIATRIC PATIENTS WITH T-CELL LYMPHOBLASTIC LYMPHOMA

EHA Library, Yonghong Zhang, 419325

RESPONSE IN MOLECULAR SUBGROUPS AND CIRCULATING TUMOR (CT)DNA KINETICS IN PATIENTS WITH RELAPSED AND/OR REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL) TREATED WITH GLOFITAMAB MONOTHERAPY

EHA Library, Carmelo Carlo-Stella, 419326

HYPERSPECTRAL IMAGING FOR NON-INVASIVE DIAGNOSIS OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A PILOT STUDY

EHA Library, Ji Ma, 419327

3D IN-VITRO RECREATED TUMOR MICROENVIRONMENT AFFECTS DLBCL DRUGS SENSITIVITY AND ALTERS THE CYTOKINE MILIEU

EHA Library, Jessica Ceccato, 419328

CDK1 INHIBITOR RO-3306 ENHANCES BTKI POTENCY IN DIFFUSE LARGE B-CELL LYMPHOMA BY SUPPRESSING JAK2/STAT3 SIGNALING

EHA Library, Liang Yu, 419329

THE BLOOD PROTEOME PREDICTS HIGH RISK OF RELAPSE IN MANTLE CELL LYMPHOMA PATIENTS

EHA Library, Patrick Nylund, 419330

IMMUNE CORRELATES OF RESPONSE TO EPCORITAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: DOSE EXPANSION IN A PHASE 1/2 TRIAL

EHA Library, Jimin Zhang, 419331

ROLE OF INFLAMMATION IN WALDENSTROM MACROGLOBULINEMIA: INSIGHTS FROM A MULTICENTER STUDY

EHA Library, Pierre-Edouard Debureaux, 419332

CD20 EXPRESSION AND RESPONSE TO ODRONEXTAMAB: BIOMARKER ANALYSIS IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R B-NHL) FROM THE ELM-2 STUDY

EHA Library, Stefano Luminari, 419333

MYELOID CLONAL HEMATOPOIESIS AFFECTS OUTCOME IN YOUNGER MANTLE CELL LYMPHOMA PATIENTS: UPDATED RESULTS FROM THE FONDAZIONE ITALIANA LINFOMI MCL0208 CLINICAL TRIAL

EHA Library, Simone Ragaini, 419334

GUT MICROBIAL SHORT-CHAIN FATTY ACIDS AS POTENTIAL CHEMICAL MODIFIER OF CAR-T CELLS FOR NON-HODGKIN LYMPHOMA

EHA Library, Roberto Garcia-Vicente, 419335

POPULATION MODELING OF AXICABTAGENE CILOLEUCEL PHARMACOKINETICS IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Sylvain Lamure, 419336

AMINO ACID INFLUX VIA LAT1 REGULATES IRON DEPENDENCY OF AGGRESSIVE NATURAL KILLER CELL LEUKEMIA

EHA Library, Ryo Yanagiya, 419337

PRECLINICAL ASSESSMENT OF IPH6501, A FIRST-IN-CLASS IL2V-ARMED TETRASPECIFIC NK CELL ENGAGER DIRECTED AGAINST CD20 FOR R/R B-NHL, IN COMPARISON WITH A CD20-TARGETING T CELL ENGAGER

EHA Library, Eric Vivier, 419338

LMP1 ENHANCED AEROBIC GLYCOLYSIS VIA COMPETITIVE BINDING WITH TRAF3 TO ACTIVE NF-ΚB PATHWAY IN NATURAL KILLER/T CELL LYMPHOMA

EHA Library, Wenting Song, 419339

ELUCIDATING THE MECHANISM OF HMGB2 IN AUGMENTING THE WARBURG EFFECT AND FACILITATING THE ONSET OF HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMA THROUGH THE REGULATION OF U2AF2 STABILITY

EHA Library, Jun Li, 419340

COMBINATION OF SELINEXOR WITH BTK INHIBITOR FOR CENTRAL NERVOURS SYSTEM DIFFUSE LARGE B-CELL LYMPHOMA, POSSIBLE MECHANISMS AND THERAPEUTIC POTENTIAL EXPLORATION

EHA Library, Xiaobo Wang, 419341

PLEIOTROPIC RISK LOCI IN LYMPHOID NEOPLASMS: PHENOCLUSTERING REVEALS NOVEL INSIGHTS

EHA Library, Murat Güler, 419342

ORAL ARV-393 IS A BCL6 DEGRADING PROTAC EFFICACIOUS AS MONOTHERAPY IN B-CELL LYMPHOMA PRECLINICAL CDX AND PDX MODELS

EHA Library, Sheryl Gough, 419343

ANTIBIOTIC-ASSOCIATED DYSBIOSIS IMPACTS ON THE PROGRESSION OF NON-HODGKIN LYMPHOMA THROUGH T CELL DYSFUNCTION

EHA Library, María Hernández-Sánchez, 419344

SINGLE CELL RNA SEQUENCING PROFILING OF ADULT T-CELL LEUKEMIA AND MOLECULAR MECHANISM OF GENE RGS13 INVOLVING IN DEVELOPMENT OF ATLL

EHA Library, Jianda Hu, 419345

RESISTANCE MECHANISMS AND CLONAL KINETICS IN MANTLE CELL LYMPHOMA TREATED WITH SEQUENTIAL BTKI AND VENETOCLAX THERAPY

EHA Library, Tamás László, 419346

TRANSLATIONAL RESEARCH TARGETING INTRACTABLE LYMPHOMAS WITH T FOLLICULAR HELPER CELL PHENOTYPE

EHA Library, Sakurako Suma, 419347

SERIAL MONITORING OF CIRCULATING TUMOR DNA WITH AN ULTRASENSITIVE ASSAY FACILITATES OUTCOME PREDICTION IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH MODERN AGENTS

EHA Library, Julia K. Schleifenbaum, 419348

HIGH-MULTIPLEX SINGLE-CELL IMAGING ANALYSIS REVEALS TUMOR IMMUNE CONTEXTURE ASSOCIATED WITH CLINICAL OUTCOMES AFTER CAR T-CELL THERAPY

EHA Library, Liting Chen, 419349

EXPRESSION OF MUTATED MYD88 IN A FEW GERMINAL CENTER B CELLS DEMONSTRATES THE ROLE OF ANTIGENIC STIMULATION IN THE CLONAL EMERGENCE OF LYMPHOPLASMACYTIC LYMPHOMA IN A NEW DUAL COLOR MOUSE MODEL

EHA Library, Ophélie Téteau, 419350

XPO1 INHIBITOR TRIGGERS AUTOPHAGY OF TP53-MUTATED BURKITT LYMPHOMA CELLS

EHA Library, Mowang Wang, 419351

COLLABORATIVE ADVANCEMENTS IN DRUG DEVELOPMENT: LEVERAGING CEVI-PDX, THE ANNOTATED LYMPHOMA PDX COLLECTION FROM FRANCE

EHA Library, Carole Soussain, 419352

MULTI-OMIC ANALYSIS OF CXCR4 AND CHROMOSOME 6Q DELETIONS IN CONTEXT OF WM SUBTYPE AND DISEASE EVOLUTION REVEAL KEY INSIGHTS INTO THE BIOLOGY OF WALDENSTROM’S MACROGLOBULINEMIA.

EHA Library, Zachary Hunter, 419353

PROGNOSTIC IMPACT OF TP53 ABERRATIONS DETECTED IN TISSUE OR CFDNA IN SPLENIC MARGINAL ZONE LYMPHOMAS

EHA Library, Ramón Diez-Feijóo Varela, 419355

COMPETITION BETWEEN AID-IMPRINTED B-CELLS OVEREXPRESSING REL OR NOT INDICATES THAT REL HAS THE CHARACTERISTICS OF A PRIMARY GENETIC EVENT FOR GERMINAL CENTER B-CELL TRANSFORMATION.

EHA Library, Nathalie Faumont, 419356

A NOVEL STAT5B-DRIVEN MOUSE MODEL OF HEPATOSPLENIC T CELL LYMPHOMA REVEALS THERAPEUTIC EFFICACY OF JAK INHIBITORS

EHA Library, Myint Myat Khine Aung, 419357

CHARACTERIZING THE MUTATIONAL LANDSCAPE OF FOLLICULAR LYMPHOMA AT DIAGNOSIS AND RELAPSE: INSIGHTS FROM MSK-IMPACT NEXT GENERATION SEQUENCING PLATFORM

EHA Library, Alfredo Rivas-Delgado, 419358

THE MULTIKINASE CDK4/6 INHIBITOR NARAZACICLIB OVERCOMES BTK-I RESISTANCE IN MANTLE CELL LYMPHOMA BY TARGETING USP24-P53 SIGNALING AXIS

EHA Library, Gaël Roué, 419359

CELL-FREE DNA GENOMIC AND FRAGMENTOMIC FEATURES FOR EARLY OUTCOME PREDICTIONS IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Steven Wang, 419360

COMPREHENSIVE CHARACTERIZATION OF MANTLE CELL LYMPHOMA REVEALS SIMILAR GENETIC, IMMUNOPHENOTYPIC AND CLINICAL FEATURES AT THE TIME OF RELAPSE AND DIAGNOSIS

EHA Library, Anna Nikkarinen, 419361

HIGH MYELOID DERIVED SUPPRESSOR CELLS AND HYPERACTIVATED T CELLS SHOW IMPAIRED IMMUNE FUNCTION YEARS AFTER THERAPY IN DLBCL SURVIVORS

EHA Library, Giulia Benintende, 419362

ONE-THIRD OF MANTLE CELL LYMPHOMA AND FOLLICULAR LYMPHOMA CASES ARE PRECEDED BY A PROLONGED MONOCLONAL B-CELL LYMPHOCYTOSIS-LIKE PRECURSOR PHASE

EHA Library, Pieter Martijn Kolijn, 419363

ACTIVATION-INDUCED CYTIDINE DEAMINASE CAUSES RECURRENT SPLICING MUTATIONS IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Pedro Medina, 419364

DISSECTING THE SINGLE-CELL LANDSCAPE OF LEUKEMIC MANTLE CELL LYMPHOMA

EHA Library, Hosna Baniadam, 419365

ANTIVIRAL PROTECTIVE SIGNATURE OF VΔ2 T CELLS IN PEDIATRIC PATIENTS AFTER ΑΒ/CD19-DEPLETED HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Chiara Agrati, 419366

MECHANISMS UNDERLYING SEIZURES AND HYPOTHERMIA DURING BUSULPHAN ADMINISTRATION

EHA Library, Ibrahim El Serafi, 419367

NEW MARKER AND TARGET: TSRNA MARKS THE ACTIVATION OF T CELLS PROVIDING EARLY DETECTION AND THERAPY OF GVHD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Lin Xia, 419368

FUCOSYLATION IS ESSENTIAL FOR HUMAN HEMATOPOIETIC STEM CELLS TETHER AND SLING FORMATION AND IN VIVO MIGRATION

EHA Library, Arwa Alghuneim, 419369

MENDELIAN RANDOMIZATION UNCOVERS CAUSAL BLOOD METABOLITES AND IMMUNE CELLS MEDIATORS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: INFLUENCE ON GRAFT-VERSUS-HOST DISEASE AND RELAPSE

EHA Library, Xinghao Yu, 419370

PRECLINICAL MODELING OF HUMAN HEMATOPOIETIC CELL XENOGRAFTS CRITICALLY RELIES ON MATCHING THE SEX OF DONORS AND RECIPIENTS

EHA Library, Syed Mian, 419371

TGF-Β1 ACTIVATING ANTIBODIES AS A TREATMENT FOR GRAFT-VERSUS-HOST DISEASE

EHA Library, Séverine Wautier, 419372

ENHANCED ENGRAFTMENT LEVELS WITH A NON-GENOTOXIC CONDITIONING REGIME FUSING MONOCLONAL ANTIBODIES AND HEMATOPOIETIC STEM AND PROGENITOR CELL MOBILIZERS

EHA Library, Isabel Ojeda Pérez, 419373

QUIZARTINIB SENSITISES HEMATOPOIETIC PROGENITORS TO DNA DAMAGING THERAPIES VIA DOWNREGULATION OF DNA DAMAGE REPAIR GENES

EHA Library, Samuel Taylor, 419374

NEW INSIGHTS INTO THE GENERATION AND ISOLATION OF TRANSPLANTABLE HEMATOPOIETIC STEM CELLS FROM HUMAN INDUCED PLURIPOTENT STEM CELLS

EHA Library, Laurence GUYONNEAU-HARMAND, 419375

A MURINE NON-CONDITIONED BONE MARROW TRANSPLANTATION MODEL TO INVESTIGATE CLONAL HEMATOPOIESIS AND MYELOID MALIGNANCIES

EHA Library, Sofia Bentivegna, 419376

HEREDITARY ALLELIC VARIATION IN THE APOE GENE AND POST-TRANSPLANTATION OUTCOMES IN ACUTE MYELOID LEUKEMIA

EHA Library, Julian Ronnacker, 419377

STUDY OF HUANGQIN DECOCTION IN TREATING INTESTINAL AGVHD BY REGULATING INTESTINAL MICROFLORA FOR ANTI-INFLAMMATION AND INTERVENTION IN AUTOPHAGY

EHA Library, xing cui, 419378

ACCESS ALL AREAS: ACUTE GVHD UNLOCKS ACCESS TO THE TISSUES FOR INVADING OLIGOCLONAL T CELLS AND DONOR MYELOID CELLS

EHA Library, Callum Wright, 419380

C-KIT X CD16A X CD47 SWITCH-DARPIN WITH CONDITIONAL BLOCKADE OF CD47: A NEXT-GENERATION TARGETED CONDITIONING FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Alexander Link, 419381

LACTATE INDUCES TH1 RESPONSE IN ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Hengwei Wu, 419382

OUTCOMES AND SAFETY OF LOW DOSE DECITABINE AND RH-GCSF MAINTENANCE THERAPY FOLLOWING ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT FOR HIGH-RISK MYELOID NEOPLASM.

EHA Library, Hassan Alkhateeb, 419383

NGS-MRD IMPROVES RELAPSE PREDICTION IN PATIENTS TRANSPLANTED FOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH POSITIVE-NON-QUANTIFIABLE QPCR MRD RESULTS

EHA Library, Krystof Seferna, 419384

ASSOCIATION BETWEEN INFUSED CD34+ CELL DOSE AND OUTCOMES IN AUTOHCT FOR NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Oren Pasvolsky, 419385

COMPARISON OF RABBIT ANTI-THYMOCYTE GLOBULINS (ATG-T) AND ANTI-T-LYMPHOCYTE GLOBULINS (ATLG) IN TBI-BASED MAC OF ALTERNATIVE DONOR HSCT FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Fang Xu, 419386

EPSTEIN-BARR VIRUS REACTIVATION ACCELERATE IMMUNE RECONSTITUTION AFTER HAPLO-PERIPHERAL BLOOD STEM CELL TRANSPLANTATION

EHA Library, Wan Liping, 419387

BROADENING ELIGIBILITY FOR HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT IN LYMPHOMA; SINGLE CENTRE EXPERIENCE OF CONDITIONING WITH ETOPOSIDE AND MELPHALAN.

EHA Library, Harriet Ambrose, 419388

IMPACT OF INSUFFICIENT TOTAL NUCLEATED CELL COUNT ON BONE MARROW TRANSPLANTATION

EHA Library, Shinsuke Kusakabe, 419389

IMPACT OF CONDITIONING INTENSITY ON VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME SEVERITY AND OUTCOMES IN ADULT HEMATOPOIETIC CELL TRANSPLANT PATIENTS: RESULTS FROM THE DEFIFRANCE REGISTRY

EHA Library, Mohamad Mohty, 419390

TBI-ATG-BASED CONDITIONING REGIMEN IMPROVED THE SURVIVAL OF ADULT PATIENTS WITH ADVANCED PERIPHERAL T-CELL LYMPHOMA AFTER HAPLOIDENTICAL ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION

EHA Library, chuxian zhao, 419391

DISTRIBUTION AND OUTCOMES ACCORDING TO WHO 2016, 2022 AND ICC IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Jacob Jendro, 419392

DELETIONS OF COMPLEMENT FACTOR H-RELATED GENES CFHR1 AND CFHR3 AND CYTOMEGALOVIRUS INFECTION AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Lars Klingen Gjærde, 419393